Advertisement
Immune System

Genomic Test May Predict Which Patients Would Benefit Most From Checkpoint Inhibition

06/08/2017

New genomic test could determine the patients who would benefit most from immunotherapy. Foundation Medicine, a molecular diagnostics company out of Cambridge, Massachusetts has created a test which determines a patient’s tumor mutation burden (TMB). Patients with high TMB have been shown to respond better to checkpoint inhibitors. The test has shown high tumor burden in cancers where checkpoint inhibitors are used in clinic as well as those where the therapy is not usually considered a viable option.

References:

  1. Schattner, E. Which patients will be helped by immune cancer drugs? This test may tell. Forbes website. https://www.forbes.com/sites/elaineschattner/2017/04/12/which-cancer-patients-will-be-helped-by-powerful-immune-drugs-this-test-may-tell/#7c4d65f3689c. April 12, 2017. Accessed April 20, 2017.
  2. Rizvi, NA et al. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 03 Apr 2015; 348(6230): 124-128. Doi: 10.1126/science.aaa1348

 

For more videos, visit our partners at The Doctor's Channel.

Related Content

Inflammatory Bowel Disease
Inflammatory Bowel Disease
Raymond Cross, MD, on the AIBD Regional Meeting at Chapel Hill
09/11/2020
In this 3-minute video, Raymond Cross, MD, of the University of Maryland IBD Center, gives a preview of the sessions planned for the Advances in Inflammatory Bowel Disease 2020 virtual regional meeting on...
09/11/2020
Stress and Burnout
Stress and Burnout
Neal S. Birnbaum, MD, FACP, MACR, on How I Practice Now: Telemedicine and Financial Challenges of the Pandemic
05/15/2020
In this video, Neal Birnbaum, MD, from Pacific Rheumatology Associates, talks about the challenges he has faced during the COVID-19 pandemic, including those associated with telemedicine and the financial...
05/15/2020
Medication Prescribing
Medication Prescribing
Prescribing Medical Marijuana?
10/04/2018
Rick Kimball discusses why clinicians may be reluctant to prescribe medical marijuana in any form.
10/04/2018
Gastroenterology
Gastroenterology
David Hudesman, MD, on Managing IBD and Nonmelanoma Skin Carcinoma
02/27/2020
In this video, Dr Hudesman, from NYU Langone Health, highlights the management of inflammatory bowel disease with nonmelanoma skin carcinoma and sun protection strategies.
02/27/2020
Inflammatory Bowel Disease
Inflammatory Bowel Disease
Walter Koltun, MD, on the Role of Diet in Ileal Pouch–Anal Anastomosis
03/03/2020
In this video, Walter Koltun, MD, from Penn State Health, discusses how a patient’s diet can influence outcomes of ileal pouch–anal anastomosis, and more.
03/03/2020